国际动态存档（2015年8月2期）

8/13 Coverage Lines Being Drawn for PCSK9 Inhibitors
8/13 Pfizer Is in Talks to Acquire GlaxoSmithKline
8/13 FDA extends review date for BMS' Opdivo
8/13 Combining chemotherapy with an immune-blocking drug could stop cancer growing back
8/13 UTHealth research: Older breast cancer patients less likely to benefit from chemo
8/13 ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma
8/13 Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumors
8/12 Orexo: U.S. FDA Approves ZUBSOLV® for Induction of Buprenorphine Maintenance Therapy in Patients Suffering from Opioid Dependence
8/12 Global Pharma Sales to Grow to $1.3 Trillion by 2018
8/12 US Biosimilars Industry Calls for Unique HCPCS Codes for Every Product
8/12 How slow can Big Pharma go in emerging markets?
8/12 Real-time data can put slow drug launches into the fast lane, researcher says
8/12 AbbVie to seek FDA approval for leukemia drug after trial success
8/12 BeiGene Announces Appointment of Dr. Howard Liang as Chief Financial and Strategy Officer
8/12 Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience
8/12 Waltham oncology biotech grows as drugs move towards market
8/11 Alzheimer’s Update: What to Make of Latest Buzz
8/11 Advantage Brintellix? Lundbeck advances bid for cognitive label claim
8/11 Talking With A Specialist About Aquinox's Enormous Day: Aquinox's Stock Price Soars Astonishing 3,000% In 4 Days
8/11 Woman Loses Vision After Mosquito Bites
8/11 Once Disparaged, 'Me-Too' Drugs Crucial For Lower Costs Of Cholesterol, Hepatitis C And Cancer Drugs
8/11 Better quality nanomedicine
8/11 Scientists present review of liposomes: A basis for drugs of the future
8/11 BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma
8/11 Cellular Biomedicine Group Appoints Former MedImmune/AstraZeneca Director, Yihong Yao, Ph.D., B.S., as Chief Scientific Officer
8/11 Beverly biotech Cellceutix comes out swinging after anonymous published attack
8/10 Bill Gates And 13 Other Investors Pour $120 Million Into Revolutionary Gene-Editing Startup
8/10 Pharma Must Move Beyond Cooperation to True Collaboration
8/10 Lilly chalks up a win for Cymbalta in first U.S. trial over withdrawal symptom claims
8/10 GSK defends low-margin strategy with a gloomy outlook for high drug prices
8/10 FDA Approves Taro’s Keveyis (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
8/10 Amarin Wins Right To Use Off Label Info For Marketing
8/10 Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills
8/10 Sorrento's TNK Therapeutics Subsidiary Acquires Multiple Clinical Stage CAR-T Immunotherapy Programs
8/10 Mallinckrodt to Acquire Therakos for $1.33 Billion
8/9 Biogen's Tecfidera faces new challenge as scientists call for monitoring for brain infections
One-Shot Drug Cures Blindness from Rare Cause: How Much is it Worth?
Feds Come Knocking on Allergan's Door
NanoSmart's targeted cancer killer gains another orphan designation for Ewing's sarcoma
US district court permits Amarin to promote off-label use of Vascepa